Fusion Micro Finance Ltd IPO

Incorporated in 1983, Kolkata-based Tarsons Products manufactures laboratory products that are used in various research organisations, pharmaceutical companies, academia institutes, hospitals and diagnostic centres.

The company plans to go public and here’s all you need to know about this IPO.

Here’s the consolidated financial information for the last three years:

• Its well diversified and extensive pan-India presence;
• Its proven execution capabilities with strong rural focus;
• Access to diversified sources of capital and effective asset liability management;
• Robust underwriting process and risk management policies
• Technologically advanced operating model;

• The extent to which the Coronavirus disease ("COVID-19") may affect its business and operations in the future is uncertain and cannot be predicted.
• The microfinance industry in India faces unique risks due to the category of borrowers that it services, which are generally not associated with other forms of lending.
• Its business is particularly vulnerable to interest rate risk, and volatility in interest rates could have an adverse effect on its net interest income and net interest margin, thereby affecting its results of operations and cash flows.
• The company is subject to laws and regulations governing the financial services industry and its operations in India and changes in, and differing interpretations of, laws and regulations governing it could adversely affect its business, results of operations and prospects.
• An increase in the level of our NPAs or its provisions may adversely affect its business, financial condition, results of operations and cash flows.

• Deepen, Strengthen and Expand Geographic Presence
• Continue to Invest in Technology to Enhance Operational Efficiency and Optimize Costs
• Leverage its Network, Domain Expertise and Data to Enhance Product Offering
• Continue to Diversify Borrowing Mix and Reduce Cost of Funds
• Deepen, Strengthen and Expand Geographic Presence